Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-077797
Filing Date
2021-06-07
Accepted
2021-06-07 17:30:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm212632-1_defa14a.htm DEFA14A 28491
  Complete submission text file 0001104659-21-077797.txt   29594
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-20713 | Film No.: 211000527
SIC: 2836 Biological Products, (No Diagnostic Substances)